Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"the act of a plaintiff dismissing a lawsuit upon settling the case. Such a dismissal may be dismissal with prejudice, meaning it can never be filed again"
Citron hitpiece out on SCOK! I knew it was coming!!!
ECYT +20% so far! Back in the gap!!!
ECYT Cantor Fitzgerald Initiates Coverage on Endocyte (ECYT) with Buy rating $21p/t!!!
Gap fill underway! Should never have fallen this far!!!
NUS in here for a quick flyer!!!
NNVC NanoViricides to Restart its Anti-Ebola Virus Drug Development Program!!!
MBLY the next GPRO? Out of the gate running!!!
Jobs report and the number is?
Dow off 300 pts looking for bargains but they may be even cheaper tomorrow!!!
Chardan Capital Affirms Endocyte (ECYT) at Buy Following Q2 Results, Operational Update $15 p/t!!!
Just listened to the CC! Don't understand the sell off it was basically all positive and moving forward!!!
GALT in for a starter!!!
Cramer just added his negative 2 cents also! Heading in the right direction!!!
NFLX 450 p/m early weakness!!!
NFLX tomorrow should be the "big dip" on the "big money"!!!
Got lucky there someone sold a bunch of premium eod. Filled down to $1.75!!!
CMG lotto ticket! Filled Buy to Open 5 CMG Jul 25 2014 650.0 Call Limit 2.00
NEWL $6 another 35% gainer...and a halt for INFO!!!
NEWL +100% nice reversal after R/S!!!
ECYT Endocyte initiated by Brean Capital at buy. $22.00 PT!
ECYT-As Merck (MRK) bails on a potential ovarian-cancer treatment developed by Endocyte (ECYT) after a late-stage study was halted in early May, RBC says the company has opportunities, including ongoing tests for the drug candidate involving other cancers. Meanwhile, "another partnership, though not needed or expected currently, could be a real possibility" as multiple firms were involved before ECYT decided to go with MRK in 2012. The investment bank also highlights the roughly $5-6/share in pro-forma cash the company has, "which combined with the upcoming events and a relatively cheap enterprise value...keep ECYT shares interesting." RBC cuts its price target 25% to $15;
Them bastids!
ECYT for the gap!!!
ECYT 7.75 squeeze has started!!!
ECYT 7.50 tag may not be done!!!
ECYT push!!!
ECYT 7.25 hod push!!!
ECYT 7.11 continues to fill that huge gap! Little R until $9.90!!!
MOS Spike may be Attributed to Unconfirmed Chatter Labeled as 'Desk Talk', Passed Along to Benzinga, of Potential Bid from BHP of $62.00/Share
ECYT looking for the 7 dolla holla!!!
BIOD 2.45 bottom bounce!!!
LIQD Federated investors inc reports 12.93 percent passive stake in Liquid!
NIHD +27% for the gap!!!
NIHD .65 making a move off the bottom!!!
IDIX +224% on Merck offer!!!
Liquid Holdings $LIQD initiated with a buy at Craig Hallum and a USD 2.50 price target!
Jefferies speculates that DISH $DISH could make a USD 45/shr bid for T-Mobile!
FIVE guidance was light...don't get the pop! Hopefully it will correct today!!!
POWR on the verge!!!